Combined pyrotinib and fulvestrant for hormone receptor‐positive and HER2‐positive metastatic breast cancer: A multicenter, single‐arm, phase II trial

Combined pyrotinib and fulvestrant for hormone receptor‐positive and HER2‐positive metastatic breast cancer: A multicenter, single‐arm, phase II trial

Abstract This multicenter, single‐arm, phase II clinical trial (NCT04034589) evaluated the efficacy and safety of pyrotinib combined with fulvestrant in patients with HR‐positive/HER2‐positive metastatic breast cancer who had experienced trastuzumab treatment failure. A total of 46 patients were enr...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jianli Zhao, Yunfang Yu, Wei Ren, Linxiaoxiao Ding, Yongjian Chen, Peng Yuan, Jian Yue, Yaping Yang, Guorong Zou, Tao Chen, Jie Chai, Li Zhang, Wenjing Wu, Yinduo Zeng, Xiujuan Gui, Yangyang Cai, Simin Luo, Zhongyu Yuan, Kang Zhang, Herui Yao, Ying Wang
Format:	Article
Language:	English
Published:	Wiley 2025-01-01
Series:	MedComm
Online Access:	https://doi.org/10.1002/mco2.70031
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Neoadjuvant pyrotinib and trastuzumab in HER2-positive breast cancer with no early response (NeoPaTHer): efficacy, safety and biomarker analysis of a prospective, multicentre, response-adapted study
by: Fei Wang, et al.
Published: (2025-01-01)

Targeting of the HER2/HER3 signaling axis overcomes ligand‐mediated resistance to trastuzumab in HER2‐positive breast cancer
by: Satomi Watanabe, et al.
Published: (2019-03-01)

Lerociclib plus fulvestrant in patients with HR+/HER2− locally advanced or metastatic breast cancer who have progressed on prior endocrine therapy: LEONARDA-1 a phase III randomized trial
by: Binghe Xu, et al.
Published: (2025-01-01)

Review of the clinical status of cardiotoxicity of HER-2 positive breast cancer targeted therapeutic drugs
by: Xiang Zhang, et al.
Published: (2025-02-01)

Maintenance Therapy with Trastuzumab in Her2 Positive Metastatic Parotid Ductal Adenocarcinoma
by: Muhammad Shahid Iqbal, et al.
Published: (2014-01-01)

Mechanisms of Resistance to Trastuzumab and Novel Therapeutic Strategies in HER2-Positive Breast Cancer
by: Andrea L. A. Wong, et al.
Published: (2012-01-01)

The woman and her inner dialogue: How Positive Psychotherapy transforms psychosomatic challenges into strength
by: Elena Drazheva, et al.
Published: (2025-01-01)

Effect of Estrogen Receptor on the Relationship Between HER2 Immunohistochemistry Score and Pathological Complete Response to Neoadjuvant Treatment in HER2-Positive Breast Cancer
by: Miaomiao Jia, et al.
Published: (2024-01-01)

Characterizing safety, toxicity, and breast cancer risk reduction using a long-term fulvestrant eluting implant
by: Scott Thomas, et al.
Published: (2025-01-01)

HER2-Positive Metaplastic Spindle Cell Carcinoma Associated with Synchronous Bilateral Apocrine Carcinoma of the Breast
by: Katsumi Kito, et al.
Published: (2014-01-01)

Phase Ib study of pembrolizumab in combination with trastuzumab emtansine for metastatic HER2-positive breast cancer
by: Sara M Tolaney, et al.
Published: (2022-10-01)

A glimpse into the future: Integrating artificial intelligence for precision HER2‐positive breast cancer management
by: Xinpei Deng, et al.
Published: (2024-09-01)

Molecular characterization and potential therapeutic roles of miR125a in HER-2 positive gastric cancer
by: Afraa Mamoori, et al.
Published: (2023-07-01)

CD36 enrichment in HER2-positive mesenchymal stem cells drives therapy refractoriness in breast cancer
by: Lorenzo Castagnoli, et al.
Published: (2025-01-01)

Investigation of <i>ITGB3</i> Heterogeneity to Overcome Trastuzumab Resistance in HER2-Positive Breast Cancer
by: Asiye Busra Boz Er
Published: (2024-12-01)

PTPN9 regulates HER3 phosphorylation during trastuzumab treatment and loss of PTPN9 is a potential biomarker for trastuzumab resistance in HER2 positive breast cancer
by: Abul Azad, et al.
Published: (2025-01-01)

Nomograms for predicting recurrence of HER2‐positive breast cancer with different HR status based on ultrasound and clinicopathological characteristics
by: Xudong Zhang, et al.
Published: (2024-09-01)

Accessible model predicts response in hormone receptor positive HER2 negative breast cancer receiving neoadjuvant chemotherapy
by: Luca Mastrantoni, et al.
Published: (2025-02-01)

Positive Filtering with l1-Gain for Discrete-Time Positive Systems
by: Xiaoming Chen
Published: (2016-01-01)

Targeting PCSK9, through an innovative cVLP-based vaccine, enhanced the therapeutic activity of a cVLP-HER2 vaccine in a preclinical model of HER2-positive mammary carcinoma
by: Laura Scalambra, et al.
Published: (2025-01-01)

The Synthesis of the Locating Substitution Derivatives of Chitosan by Click Reaction at the 6-Position of Chitin
by: Yu Chen, et al.
Published: (2015-01-01)

Optimal Position and Velocity Estimation for Multi-USV Positioning Systems with Range Measurements
by: Wei Chen, et al.
Published: (2018-01-01)

Experimental Investigation of the Impact of Necking Position on Pile Capacity Assisted with Transparent Soil Technology
by: Qingnian Yang, et al.
Published: (2022-01-01)

Positive Periodic Solutions of an Epidemic Model with Seasonality
by: Gui-Quan Sun, et al.
Published: (2013-01-01)

Immediate-Early Genes and Delayed Primary Response Genes Regulated by NmU in SKBR3 HER-2 Positive Breast Cancer Cell Line
by: Jessica Murphy, et al.
Published: (2019-09-01)

Case report: Near-complete response to neratinib-based treatment in HR-positive HER2-amplified metastatic breast cancer refractory to trastuzumab deruxtecan
by: Ünal Metin Tokat, et al.
Published: (2025-01-01)

Letter Position Dyslexia in Arabic: From Form to Position
by: Naama Friedmann, et al.
Published: (2012-01-01)

Resolvent Positive Operators and Positive Fractional Resolvent Families
by: Nan-Ding Li, et al.
Published: (2021-01-01)

Surgical treatment after neoadjuvant systemic therapy for HER2-positive invasive breast cancer in the Netherlands: 10-Year trends and the influence an accompanying DCIS component
by: Roxanne A.W. Ploumen, et al.
Published: (2025-02-01)

Rapid left ventricular dimension normalization following transcatheter ventricular septal defect closure in children
by: Hui Yuan, et al.
Published: (2025-02-01)

Role of drug-induced sleep endoscopy in evaluation of positional vs non-positional OSA
by: Ming-Chin Lan, et al.
Published: (2020-12-01)

Research on End-Effector Position Error Compensation of Industrial Robotic Arm Based on ECOA-BP
by: Wenping Xiang, et al.
Published: (2025-01-01)

‘Her Room Was Her World’: Nellie Sloggett and North Cornish Folklore
by: Simon Young
Published: (2017-12-01)

Her mistletoe miracle
by: FOx Roz Denny
Published: (2008)

A Convex Approach for Trajectory Optimization of Super-Synchronous-Transfer-Orbit Large Launch Systems with Time-Position Constraints
by: Yuan Li, et al.
Published: (2022-01-01)

Positive Discipline for Youth
by: Keith G. Diem, et al.
Published: (2014-09-01)

Positive Discipline for Youth
by: Keith G. Diem, et al.
Published: (2014-09-01)

Psychosynthesis in Positive Psychotherapy
by: Zlatoslav Arabadzhiev, et al.
Published: (2025-01-01)

Determination of an Indoor Target Position: An Accurate and Adaptable Approach Based on Differential Positioning
by: Siye Wang, et al.
Published: (2019-01-01)

Positive Solutions of Fractional Differential Equation with -Laplacian Operator
by: Teng Ren, et al.
Published: (2013-01-01)